On 2025-05-13, Acumen Pharmaceuticals, Inc. (ABOS) announced earnings per share of $-0.48 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.56.
The next expected annoucement date for quarterly earnings is 2025-08-12, with an average estimated earnings per share of $-0.54 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-13 | 2025-03-31 | $-0.56 | $-0.48 |
| 2025-03-27 | 2024-12-31 | $-0.47 | $-0.62 |
| 2024-11-12 | 2024-09-30 | $-0.36 | $-0.50 |
| 2024-08-13 | 2024-06-30 | $-0.28 | $-0.34 |
| 2024-05-14 | 2024-03-31 | $-0.23 | $-0.25 |
| 2024-03-26 | 2023-12-31 | $-0.29 | $-0.29 |
| 2023-11-13 | 2023-09-30 | $-0.31 | $-0.24 |
| 2023-08-08 | 2023-06-30 | $-0.36 | $-0.28 |
| 2023-05-09 | 2023-03-31 | $-0.33 | $-0.28 |
| 2023-03-27 | 2022-12-31 | $-0.28 | $-0.32 |
| 2022-11-14 | 2022-09-30 | $-0.27 | $-0.26 |
| 2022-08-15 | 2022-06-30 | $-0.24 | $-0.25 |
| 2022-05-16 | 2022-03-31 | -- | $-0.23 |
| 2021-11-15 | 2021-09-30 | $-0.21 | $-0.10 |
| 2021-08-16 | 2021-06-30 | $-0.23 | $-7.91 |